Steroid hormones reduced in ring-A are devoid of hormonal activity. In metabolic experiments we found that human fecal flora reduced the Az4-3-keto structure of natural progestins to 3ot-hydroxy, 5A-steroid metabolites (3cx,5,B) and of synthetic progestins to a mixture of 3cx,53 and 3I,5r compounds. 3cx,5r-Reductase was synthesized by Clostridium paraputrificum and had a strong affinity for natural progestins such as progesterone. 3r,513-Reductase was synthesized by Clostridium innocuium and had a stronger affinity for synthetic progestins. A third enzyme, 3r,5ct-reductase, was synthesized by St. Luke's strain 209 (Clostridium species "J-1") but was only observed when pure cultures were used. Ring-A reduction of synthetic progestins was 3 to 10 times slower than that of natural progestins, thus explaining the pharmacological superiority of synthetic progestins over naturally occurring analogs.
The metabolism of synthetic progestins, which are components of oral contraceptives, was extensively studied in the late 1960s and early 1970s (5, 6, 9, 11, 12, 14, 16) . The observed transformations, including oxidations and reductions, were attributed largely to hepatic enzymes. The fact that synthetic progestins, like other steroid hormones, undergo enterohepatic circulation (1) and therefore are exposed to bacterial enzymes in the intestinal stream was not considered. In this study we describe the role of the human intestinal flora in the transformation of synthetic progestins. Particular emphasis is placed on the bacterial species synthesizing the enzyme responsible for the metabolism.
MATERIALS AND METHODS
Abbreviations and trivial names. The abbreviations and trivial names used in the text are as follows:
cortisol, 113,17c,21-trihydroxy-4-pregnene-3,20-dione; deoxycorticosterone, 21-hydroxy-4-pregnene-3,20-dione; 21-deoxycortisol, 11,B,17a-dihydroxy-4-pregnene-3,20-dione; dihydronorethindrone, 19-nor17a -ethynyl -17,B -hydroxy -5,f -androstan -3 -one; dimethisterone, 19-nor-17a-methylethynyl-17f3-hydroxy-6ot-methyl-4-androsten-3-one; 3ax-HSDH, 3cx-hydroxysteroid dehydrogenase; norethindrone, 19-nor-17a -ethynyl -17 -hydroxy -4-androsten -3-one; norgestrel, 13f,-ethyl-177a-ethynyl-17f3-hydroxy-gon-4-en-3-one; pregnanolone, 3oa-hydroxy-5p-pregnan-20-one; progesterone, 4-pregnene-3,20-dione; tetrahydronorethindrone, 19-nor-17a-ethynyl-3cx,17f-dihydroxy-53-androstane; TLC, thin-layer chromatography.
Origin of bacteria. All three Clostridium species were isolated from human fecal flora: Clostridium paraputrificum by dilution technique (4) and Clostridiurn innocuum and St. Luke's strain 209 by the dilution and replicate-plating technique described by Macdonald et al. (13) . The Analysis. Conversion experiments and extraction and purification of metabolites by TLC and identification by TLC, gas liquid chromatography, and gas liquid chromatography-mass spectrometry have been described previously (4, 19) .
Enzymatic reaction for identification of 3a-hydroxy steroids was carried out in solution as described by Yamaguchi (20) .
Identification of metabolites. A metabolite was considered identical to a given reference compound when (i) it had a molecular weight and mass spectrometry fragmentation pattern identical to those of the reference compound; (ii) its RJ value on TLC and relative retention time to 5a-cholestane on gas liquid chromatography agreed within 4% with those of the reference compound; and (iii) the reactivities of the unknown and the reference compounds with 3a-HSDH were identical (Tables 1 and 2 ). Identification of metabolites for which reference compounds were not available was based on: (i) mass spectrometry, (ii) relative polarity as measured by TLC and gas liquid chromatography, (iii) reactivity with 3a-HSDH, and (iv) stereospecificity of enzymatic modification of a similar substrate for which reference compounds were available.
RESULTS
Mass spectra of metabolites of synthetic progestins. The extracted metabolites were converted to the volatile methoxime-trimethylsilyl ether derivatives. The mass spectrum of the tetrahydro metabolite of norgestrel is shown in Fig. 1 Figure  1 shows that the norgestrel metabolite had two hydroxy groups but no keto groups. Moreover, the molecular weight was 4 mass units higher than the molecular weight of the substrate, indicating a reduction of both the keto group and the double bond. The base peak of M+ -29 reflected the loss of the ethyl group.
It is noteworthy that the ring-A isomers of a given tetrahydro compound showed the same fragmentation pattern.
Conversion of natural steroids. Progesterone (Fig. 2) , 11i,17,-dihydroxy-4-androsten-3-one, cortisol, 21-deoxycortisol, and deoxycorticosterone were all reduced in ring-A by mixed human Norethindrone acetate incubated with fecal flora was quickly hydrolyzed and concomitantly reduced to the mixture of 3a,51 and 31,51 metabolites. It is noteworthy that fecal flora could be diluted to 109 and still perform the hydrolysis, whereas reduction of ring-A was not obtained with fecal dilutions above 107, suggesting that different organisms are responsible for the two reactions. The transformation of norethindrone by fecal flora was adequately explained by the presence of C. paraputrificum and C. innocuum. Clostridium species J-1 did not appear to play an important role in this conversion.
Kinetics reduction by pure cultures of steroid-converting organisms.
C. paraputrificum, C. innocuum, and Clostridium species J-1 all quantitatively reduced ring-A of natural progestins. In contrast, ring-A reduction of synthetic progestins was slow, taking 6 to 7 days to reduce about 70% of the molecules (Fig. 3) .
C. paraputrificum reduced the synthetic progestins in a two-step reaction, best observed with the substrates norethindrone and dimethisterone (Fig. 4) . Within 18 to 24 h, the substrate was quantitatively reduced to dihydronorethindrone, which over the next 6 to 7 days was partially reduced to tetrahydronorethindrone. Dihydro intermediates were not observed in metabolic experiments with fecal flora or with C. innocuum and Clostridium species J-1.
Under the conditions we used, the maximum amount of natural progestins converted in 24 h by the three Clostridium species was 9 mg per 50 ml of medium. These species had a 3 to 10 times lower capacity to reduce synthetic progestins, as comnpared with the natural compounds. The reduction rate, however, varied with the chemical structure of the synthetic progestins.
Substrate competition among C. paraputrificum, C. innocuum, and Clostridium species J-1. As observed above, ring-A reduction of progestins by fecal flora reflected the enzymatic activity of C. paraputrificum and, to a lesser degree, of C. innocuum. Clostridium species J-1 activity was not expressed. In experiments with mixed cultures of Clostridium species (Table 3) , C. paraputrificum had a greater affinity for natural progestins, whereas C. innocuum and Clostridium species J-1 were more active upon synthetic progestins. In mixtures of C. innocuum and Clostridium species J-1, the enzymatic expression of C. innocuum, i.e., the formation of the 3P,5P isomer, prevailed.
DISCUSSION
Origin of bacterially synthesized steroid-inactivating enzymes. The predominant and perhaps the sole effect of the intestinal flora on the synthetic progestins studied in the present investigation is the reduction of the A4-keto structure of ring-A. For almost 10 years it has been known that the human intestinal flora contains bacteria capable of reducing ring-A and thereby inactivating endogenous progestins (4). Our observations show that at least three Clostridium species synthesize ring-A active enzymes with different affinities and different stereochemical effects. The enzyme produced by C. paraputrificum is particularly active upon natural progestins, whereas those produced by C. innocuum and Clostridium species J-1 are relatively more active upon the synthetic progestins used for contraceptive purposes. Whether the observed differences in their abilities to reduce ring-A of the substrates are due to differences between synthesis of the enzyme in mixed flora or differences in enzymatic affinity for the substrates is unknown. Presently, it is difficult to offer a convincing hypothesis for the existence of three different A4-3-keto reductases, namely, 3a,5,1-, 33,5p-, and 3P,5a-reductases, all acting upon ring-A.
Preservation of contraceptive properties of synthetic progestins. Our experiments show that the minimal loss of biological activity of synthetic progestins in the intestinal environment is attributable to the ethynyl group which enhances the resistance of ring-A to reducing enzymes. It is more difficult to explain the rare failure of these contraceptive hormones in women receiving antibiotic therapy (3, 8, 17) . Perhaps the antibiotics reduce the intestinal population of deconjugating bacteria and thereby promote a substantial loss of hepatically conjugated hormones through fecal excretion. Alternatively, it is possible that alteration of the flora results in a relative increase in the population of ring-A reducing bacteria, i.e., the reducing organism might be resistant to the administered antibiotics and multiply at the expense of sensitive intestinal strains.
Sites of inactivation of progestins. Natural progestins are inactivated mainly in the liver through reduction of the double bonds (10, 15) . However, the small proportion of A4-3-keto steroids which enters the enterohepatic circulation undergoes hydrogenation by the intestinal flora to form ring-A saturated hydroxy steroids. In contrast, the hepatic reduction of the A4-3-keto structure of synthetic progestins is slow and incomplete, allowing the majority of molecules to enter the general circulation and perform their hormonal functions. The synthetic progestins undergoing enterohepatic circulation (1, 2) are slowly reduced by bacterial enzymes as described above.
For patients treated with norgestrel, Sisenwine et al. (16) noted that all four variants of the hydrogenated M4-3-keto function (ot,5o; 3ot,51; 3P,5ca; and 3P,51) appeared in urine and feces.
Evidence suggests that the human liver is capable of performing the 3ot,5p reduction, but whether it synthesizes the other reductases is unknown. Our results show that intestinal Clostridium species synthesize at least three of the reductases active upon ring-A. If it is permissible to apply the results from animal experiments (7, 18) to the human situation, it seems likely that ring-A reduction of synthetic progestins is carried out both by the liver and by certain intestinal Clostridium species.
